Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.
about
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesHuman transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cellsImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseAn integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profilingPeptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgroundsQuantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations.Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells.Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccinesStatistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity.Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityCD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype.The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infectionPorcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificitiesDifferential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.Quantitative approaches to computational vaccinology.Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.Population of the HLA ligand database.Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules.MHC Class II Binding Prediction by Molecular Docking.Use of proteomics to define targets of T-cell immunity.Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC allelesThe cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitisIrradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccinesStructural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.Designer glycopeptides for cytotoxic T cell-based elimination of carcinomasRational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humansImmunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.Factors influencing immunodominance hierarchies in TCD8+ -mediated antiviral responses.
P2860
Q21034050-CBEBBBCC-9579-44AF-8AAF-76F6C5C3827FQ27472879-2046DF3E-E9BD-4F1F-A45C-D0F1F09C93F7Q27478466-1F846E85-10D6-45F3-98DC-C48A129A9D84Q27485141-678C7D70-A6CE-4DE3-AD52-D384FDEC2C0FQ28238379-1C2EEDFB-B592-455B-9AED-32BC37DB1B40Q28534916-49BB19B6-213C-492E-BF1F-169AB12BA28CQ30413358-29196E0D-E608-4FEC-9130-DCE349D1D84DQ30532816-E07B0854-0F77-4CFF-9BBF-88F716C63C8AQ31974998-68F8961D-4D4C-4B78-AC65-19AE93C857BFQ33179056-099FD89E-F889-4969-B683-0D35707CCB1DQ33210436-02BA6BE5-3679-435A-9B68-7D1CA4BD269EQ33237064-C1334810-BC74-4A8D-8F40-863D672A00FAQ33459720-8FA1A422-613B-4CC6-8F21-229822BF23C0Q33812154-5F361299-6C34-48A1-BE60-F3BBD8166799Q33835440-2AEE119F-4BA6-4234-B7CE-854623CF3BFEQ33931464-F7596D20-0231-4111-B6ED-E8C5AD134CC8Q33952695-0108EBE6-0BBA-4F42-B32A-B3E76FCF9FDEQ33955589-2B42D962-A957-421D-BFC3-45E13DA1E7A0Q34406009-37CC8E40-8C56-445B-96BC-E93762B5F9A8Q34687630-AB45101A-7141-4429-8593-AFD001228C4DQ34744724-87FB51B8-6F5D-464E-AFD6-67C5E86C18DBQ35005969-46830098-5BA7-4A09-832A-E3F005DFDC88Q35080071-ADAB94E6-CA4F-4332-872D-25D7AC8C3F8DQ35887911-26DD77C3-20B9-4FD0-86D5-6695EF9040D0Q35951928-F27B2B2E-7F4B-4140-B668-CFE9C156D3F2Q36088285-052BF9A5-01B1-4175-923C-354BD8AE358EQ36184807-37B19A0C-874F-4B9A-9D34-2CE58842F319Q36282171-EA7F3B9C-222D-42AE-8BB6-D82F139172D4Q36364632-0772E0A8-0C5D-487C-BA41-900647A61DE5Q36365487-7594149A-2FC0-41FF-83E1-AB88D58CEDE8Q36366405-7B8B8FB2-6DD5-43BC-A858-DE4955C8094FQ36376346-3D035FCB-DA90-46CB-989D-926B58AE5861Q36403882-602DB163-28C8-4304-9113-6A3CA41C8BBCQ36423998-3085E2CF-0F56-449B-AE9E-DAEFD7EC6D48Q36499204-1D39A1E8-F5CF-459D-A69D-771688A72875Q36994720-FD54B2D9-D80B-4E42-80BE-F929797427CBQ37374471-69B1B471-7204-4A00-8ACA-AD255DDC0277Q37382996-A5025BD2-93C0-4D17-A2E7-163915A8E5FBQ37385100-EB790C45-A8C0-4255-B55F-2E009F7F9F17Q37754754-EE5463DA-38F8-4F0E-99EE-53F1A979FF5D
P2860
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Peptide binding to the most fr ...... tive molecular binding assays.
@en
type
label
Peptide binding to the most fr ...... tive molecular binding assays.
@en
prefLabel
Peptide binding to the most fr ...... tive molecular binding assays.
@en
P2093
P1433
P1476
Peptide binding to the most fr ...... tive molecular binding assays.
@en
P2093
Dahlberg C
Southwood S
del Guercio MF
P304
P356
10.1016/0161-5890(94)90019-1
P577
1994-08-01T00:00:00Z